Gateway Genomics SneakPeek Noninvasive Prenatal Test (NIPT) Identifies Gender with Cell-free Fetal DNA from Microvolumes of Self-collected Maternal Blood
Gateway Genomics, a leading developer of genomic tests that give families insight into their future children, announces a new publication titled, “Self-Collection of Maternal Blood for Fetal Sex Determination Using Cell-Free DNA” in the journal of Pregnancy and Child Health. Previous studies had only shown early gender determination using venous blood. When translated into practice, this meant women had to travel to licensed phlebotomists to have their blood drawn intravenously, which limited access to noninvasive prenatal tests. The new paper opens the possibility for women to self-collect as little as 7-10 drops of blood from a finger stick in the comfort of their home and learn the gender of their unborn baby. In this study, fetal sex was determined with 100% accuracy.
SneakPeek Clinical Greater Than 99% Accurate for Fetal Sex at 9 Weeks into Pregnancy – SneakPeek Early Gender Test Results Published in Journal of Pregnancy and Child Health
LA JOLLA, Calif.–(BUSINESS WIRE)–The Journal of Pregnancy and Child Health published a SneakPeek Clinical study that is exciting news for low-risk pregnant women seeking to know the gender of their baby. Typically, only high-risk pregnancies are eligible for insurance coverage for prescription-based NIPTs. As for everyone else, the cost of entry can be in the thousands. With this new publication, SneakPeek proves that no longer has to be.
Gateway Genomics Launches SneakPeek® Early Gender Test and Shifts NIPT Testing to a Highly Affordable, Easy to Use At-Home Version
Validation Study Proves Accuracy of Home Version of DNA Prenatal Gender Test and Enables Broad Accessibility
BALTIMORE–(BUSINESS WIRE)–Gateway Genomicsdemonstrates the accuracy of its advanced prenatal technology in a validation study showcased at the American Society of Human Genetics Conference. After previously overcoming a twenty-year roadblock of current non-invasive maternal venous blood collection by proving it is possible to accurately determine gender from maternal capillary blood, they have now made the technology available to the public in an at-home test.